These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Multimodal Therapy for Stage III Retinoblastoma (International Retinoblastoma Staging System): A Prospective Comparative Study. Chawla B; Hasan F; Seth R; Pathy S; Pattebahadur R; Sharma S; Upadhyaya A; Azad R Ophthalmology; 2016 Sep; 123(9):1933-9. PubMed ID: 27449712 [TBL] [Abstract][Full Text] [Related]
7. Role of chemotherapy alone or in combination with hyperthermia in the primary treatment of intraocular retinoblastoma: preliminary results. Levy C; Doz F; Quintana E; Pacquement H; Michon J; Schlienger P; Validire P; Asselain B; Desjardins L; Zucker JM Br J Ophthalmol; 1998 Oct; 82(10):1154-8. PubMed ID: 9924303 [TBL] [Abstract][Full Text] [Related]
8. High-dose cyclophosphamide, carboplatin, and etoposide with autologous stem cell rescue in patients with breast cancer. deMagalhaes-Silverman M; Rybka WB; Lembersky B; Bloom EJ; Lister J; Pincus SM; Voloshin M; Wilson J; Ball ED Am J Clin Oncol; 1996 Apr; 19(2):169-73. PubMed ID: 8610643 [TBL] [Abstract][Full Text] [Related]
9. High-dose melphalan, etoposide, and carboplatin followed by autologous stem-cell rescue in pediatric high-risk recurrent Wilms' tumor: a French Society of Pediatric Oncology study. Pein F; Michon J; Valteau-Couanet D; Quintana E; Frappaz D; Vannier JP; Philip T; Bergeron C; Baranzelli MC; Thyss A; Stephan JL; Boutard P; Gentet JC; Zucker JM; Tournade MF; Hartmann O J Clin Oncol; 1998 Oct; 16(10):3295-301. PubMed ID: 9779704 [TBL] [Abstract][Full Text] [Related]
10. A dose-escalation study of carboplatin/cyclophosphamide/etoposide along with autologous bone marrow or peripheral blood stem cell rescue. Shea TC; Storniolo AM; Mason JR; Newton B; Mullen M; Taetle R; Green MR Semin Oncol; 1992 Feb; 19(1 Suppl 2):139-44. PubMed ID: 1411625 [TBL] [Abstract][Full Text] [Related]
11. High-dose chemotherapy with autologous stem cell rescue in children with retinoblastoma. Kremens B; Wieland R; Reinhard H; Neubert D; Beck JD; Klingebiel T; Bornfeld N; Havers W Bone Marrow Transplant; 2003 Feb; 31(4):281-4. PubMed ID: 12621463 [TBL] [Abstract][Full Text] [Related]
12. Outcome of patients with recurrent medulloblastoma or central nervous system germinoma treated with low dose continuous intravenous etoposide along with dose-intensive chemotherapy followed by autologous hematopoietic stem cell rescue. Grodman H; Wolfe L; Kretschmar C Pediatr Blood Cancer; 2009 Jul; 53(1):33-6. PubMed ID: 19326417 [TBL] [Abstract][Full Text] [Related]
13. Results of a prospective study for the treatment of unilateral retinoblastoma. Chantada GL; Fandiño AC; Guitter MR; Raslawski EC; Dominguez JL; Manzitti J; de Dávila MT; Zubizarreta P; Scopinaro M Pediatr Blood Cancer; 2010 Jul; 55(1):60-6. PubMed ID: 20486172 [TBL] [Abstract][Full Text] [Related]
14. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue. Hagemeister FB Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984 [TBL] [Abstract][Full Text] [Related]
15. Phase II study of high-dose cyclophosphamide, etoposide, and carboplatin (CEC) followed by autologous hematopoietic stem cell rescue in women with metastatic or high-risk non-metastatic breast cancer: multivariate analysis of factors affecting survival and engraftment. Klumpp TR; Goldberg SL; Magdalinski AJ; Mangan KF Bone Marrow Transplant; 1997 Aug; 20(4):273-81. PubMed ID: 9285541 [TBL] [Abstract][Full Text] [Related]